Straumann Holding AG
SIX:STMN
Straumann Holding AG
Capital Expenditures
Straumann Holding AG
Capital Expenditures Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Straumann Holding AG
SIX:STMN
|
Capital Expenditures
-CHf223.5m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
N/A
|
|
|
Metall Zug AG
SIX:METN
|
Capital Expenditures
-CHf36.6m
|
CAGR 3-Years
0%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
|
|
Sonova Holding AG
SIX:SOON
|
Capital Expenditures
-CHf116.3m
|
CAGR 3-Years
5%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-3%
|
|
|
Medacta Group SA
SIX:MOVE
|
Capital Expenditures
-€112.4m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
N/A
|
|
|
Medmix Ltd
SIX:MEDX
|
Capital Expenditures
-CHf41.1m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
Straumann Holding AG
Glance View
Straumann Holding AG, headquartered in Basel, Switzerland, has carved a niche in the dental industry by consistently positioning itself at the forefront of innovation and quality. Established in 1954, the company originally delved into alloys used in timepieces and measurement instruments, but it soon pivoted towards medical technology beneath the visionary leadership that embraced research and development. Today, Straumann is a formidable player in the sphere of dental implants, prosthetics, and orthodontic solutions. The company is driven by a simple yet impactful mission: to provide dentists and their patients with the tools and treatments necessary to restore smiles and enhance oral health. Through a robust network of subsidiaries and partners worldwide, Straumann's reach extends to more than 100 countries, facilitating both the manufacturing and distribution of its products on a global scale. The engine behind the company’s success is its dedication to innovation, customer focus, and education. By investing heavily in R&D, Straumann develops cutting-edge products that address the evolving needs of patients and dental professionals. The company's revenue streams primarily originate from the sale of dental implants, restorative products, and digital equipment, making it a major player in both the premium and value segments of the market. Beyond its product offerings, Straumann thrives by training dental professionals through its comprehensive educational initiatives, ensuring its clients are well-prepared to deliver the highest standard of care. This synergistic approach not only amplifies customer loyalty but also firmly establishes Straumann as a trusted leader in the industry.
See Also
What is Straumann Holding AG's Capital Expenditures?
Capital Expenditures
-223.5m
CHF
Based on the financial report for Dec 31, 2025, Straumann Holding AG's Capital Expenditures amounts to -223.5m CHF.
What is Straumann Holding AG's Capital Expenditures growth rate?
Capital Expenditures CAGR 5Y
-22%
Over the last year, the Capital Expenditures growth was -33%. The average annual Capital Expenditures growth rates for Straumann Holding AG have been -5% over the past three years , -22% over the past five years .